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Introduction
Congenital absence of a maxillary lateral incisor and of 
mandibular second premolars are the two most frequent 
forms of hypodontia, their frequency varying with the 
population studied (Grahnén, 1956; Horowitz, 1966; 
Alvesalo and Portin, 1969; Muller et al., 1970; Thilander 
and Myrberg, 1973; Magnusson, 1977; Rolling, 1980; 
Aasheim and Øgaard, 1993; Johannsdottir et al., 1997; 
Tavajohi-Kermani et al., 2002; Polder et al., 2004). Values 
ranging between 0.8 and 4.25 per cent have been found for 
the prevalence of permanent maxillary lateral incisor 
agenesis (MLIA). In the Portuguese population, prevalence 
of MLIA was estimated at 1.3 per cent (Pinho et al., 2005). 
Svinhufvud et al. (1988) and Arte et al. (2001) have 
proposed that dental absence, microdontia, or the conical 
form of one or more maxillary lateral incisor are different 
expressions of the same trait.
In spite of recent progress, the aetiopathogenesis of 
hypodontia remains largely unknown (Vastardis, 2000; 
Kapadia et al., 2007). There is evidence that congenital 
tooth absence can be the result of environmental or 
hereditary causes, or of their interaction (Schalk-van der 
Weide and Bosman, 1996; Swinnen et al., 2008). However, 
as the development of the human dentition in terms of 
structure and organization is under genetic control and 
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SUMMARY The observation that certain patterns of tooth agenesis occur more frequently in individuals of 
the same family may suggest the existence of predisposing genetic factors. The aim of this study was to 
search for mutations in the PAX9 and MSX1 genes and to investigate their potential association with the 
maxillary lateral incisor agenesis (MLIA) phenotype in 12 Portuguese families, a total of 52 individuals, 
12 probands and 40 relatives (eight of which had MLIA). Twenty-three of the subjects were male and 
29 female with an age range of 10–75 years. The control group comprised random DNA samples of 91 
Portuguese individuals.
Nucleotide alterations were not detected in the coding regions of the MSX1 gene, analysed by single-
strand conformation polymorphism and sequencing; in the PAX9 gene, a polymorphism was found that 
led to transition of G718 to C, implying a change of alanine 240 for proline. However, the differences in the 
frequencies of the PAX9 gene polymorphism between the probands (67 per cent) and the control population 
(56 per cent carrying the c allele) were not statistically significant as determined by chi-square test, and the 
polymorphism did not clearly segregate with the trait in the families. Aggregating the available data, there 
does not seem to exist a clear association between the alanine 240 for proline variant in the PAX9 gene and 
the MLIA phenotype. Further studies are required to clarify the basic genetics of MLIA.
involves several factors (Lyngstadaas et al., 1996; Pirinen 
et al., 1996; Thesleff, 1996; Vastardis et al., 1996; Stockton 
et al., 2000; Vastardis, 2000; Nieminen et al., 2001; 
Das et al., 2002; Lidral and Reising, 2002; Klein et al., 
2005; Gerits et al., 2006; Mostowska et al., 2006; Kapadia 
et al., 2007; Tallon-Walton et al., 2007; Zhao et al., 2007), 
it is logical to assume that mutations in some genes encoding 
these factors may affect the normal development of teeth 
and, eventually, may cause their absence.
Inactivation of MSX1 and PAX9 genes in mice showed 
that these genes are relevant to dental and craniofacial 
development (Satokata and Maas, 1994; Neubuser et al., 
1997). Some mutations associated with tooth agenesis have 
been identified in humans in the MSX1 (Vastardis et al., 
1996; Lidral et al., 1998; Lidral and Reising, 2002; 
Mostowska et al., 2006) and PAX9 (Schuffenhauer et al., 
1999; Stockton et al., 2000; Nieminen et al., 2001; Das 
et al., 2002; Pereira et al., 2006; Hansen et al., 2007; Tallon-
Walton et al., 2007; Zhao et al., 2007; Guala et al., 2008) 
genes. Vastardis et al. (1996) identified one missense 
mutation in MSX1 (Arg31Pro), resulting in the substitution 
of arginine by proline in position 31 of the peptide chain, in 
all affected members of one family, with congenital absence 
of the second premolars and third molars as a predominant 
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congenital absence of the first premolars, first mandibular 
molars, one or both maxillary lateral incisors, or one 
mandibular central incisor.
Van den Boogaard et al. (2000) found a nonsense mutation 
(Ser104Stop) in the MSX1 gene in all affected individuals 
of a Dutch family with several combinations of orofacial 
clefting and dental agenesis (predominantly of the second 
premolars and molars). This phenotype is similar to that 
which occurs as the result of MSX1 gene mutation in mice 
(Satokata and Maas, 1994).
Nevertheless, Nieminen et al. (1995), in a study of families 
with slightly different clinical features (incisor and premolar 
hypodontia), excluded the MSX1 and MSX2 genes as 
potentially implicated in hypodontia, as well as epidermal 
growth factor (EGF), EGFR and EGF-3 (Arte et al., 1996). 
A study performed in individuals of Brazilian origin with 
hypodontia failed to find mutations in MSX1 (Scarel 
et al., 2000). Lidral and Reising (2002) did not find mutations 
in MSX1 in subjects with simple incisor and premolar 
agenesis nor in those with orofacial clefts, but they did detect 
them in families with multiple agenesis, indicating a different 
aetiology for these cases. Mostowska et al. (2006) described 
a novel mutation of MSX1 that might be responsible for 
oligodontia (lack of 14 permanent teeth in a proband), 
although with incomplete penetrance.
Peters et al. (1998), in animal studies of gene inactivation, 
showed that the expression of transcription factors dependent 
on PAX9 regulation was essential to the normal development 
of structures derived from the pharyngeal pouch, such as 
the craniofacial skeleton, teeth, and fingers. Affected mice 
died in the prenatal period, presumably due to serious 
craniofacial malformations, including palatal fissures. 
Peters et al. (1998) also showed that the PAX9 gene is 
fundamental for the mesenchymal expression of transcription 
factors: bone morphogenetic protein 4 (Bmp4), MSX1, and 
lymphoid enhancer-binding factor 1 (Lef1), suggesting a 
role for this gene in the establishment of the inductive 
capacity of the mesenchyme in tooth formation.
In humans, mutations in PAX9 were identified in individuals 
with oligodontia, affecting mostly the molars, suggesting the 
importance of the expression of that gene for the formation of 
the dentition (Stockton et al., 2000; Nieminen et al., 2001; 
Pereira et al., 2006; Hansen et al., 2007; Tallon-Walton et al., 
2007). Lammi et al. (2004), recently, reported that a nonsense 
mutation in AXIN2, an essential component of the WNT/ -
catenin pathway, caused familial oligodontia with a severe 
phenotype. In addition to oligodontia, those authors also 
found that a mutation in AXIN2 predispose the individual to 
colorectal cancer. However, considering the discrepancy 
between the high prevalence rate of tooth agenesis and the 
relatively small number of reported causative mutations in 
the PAX9, MSX1, and AXIN2 genes, the genetic contribution 
to hypodontia/oligodontia seems quite heterogeneous (Gerits 
et al., 2006). Environmental and epigenetic factors as well as 
genes regulating odontogenesis require further in vivo and 
in vitro investigation in order to explain the phenotypic 
heterogeneity and to increase understanding of the 
odontogenic processes (Swinnen et al., 2008).
A study of familiar aggregation showing that the risk of a 
relative of an individual with maxillary lateral incisor 
agenesis (MLIA) having the same type of agenesis was 
13–15 times higher when compared with a relative of an 
individual without agenesis (Pinho, 2004) has reinforced 
the hypothesis that genetic changes may lead to congenital 
absence of teeth. Thus, the current study aimed to evaluate 
a possible association between mutations in MSX1, PAX9, 
and the MLIA phenotype in patients of Portuguese origin.
Subjects and methods
All participants gave their written informed consent to 
participation in this study, which was approved by the Ethics 
Committee of the Faculty of Dental Medicine of the 
University of Porto.
Patients and controls
A previous epidemiological study involving analysis of 
16 771 patients between 1993 and 2000 at a university clinic 
led to the identification of 219 subjects with permanent 
MLIA, corresponding to a prevalence of 1.3 per cent in this 
population (Pinho et al., 2005).
Comprehensive clinical information, family history, and 
radiographs were obtained for 52 of the above-mentioned 
individuals, 12 probands, and 40 relatives (eight of which had 
MLIA; families 1–12); 23 (44.2 per cent) of the subjects were 
male and 29 (55.8 per cent) female, and their age ranged 
from 10–75 years (mean 33.48  17.37; Figure 1, available 
as supplementary data on European Journal of Orthodontics 
online). Care was taken during clinical observation to exclude 
known genetic syndromes associated with tooth absence, and 
records were made of all skin, hand, eye, lip, and palatal 
anomalies, as well as hearing problems. Random DNA 
samples of 91 Portuguese individuals (obtained from 
anonymous Guthrie cards, from the national newborn 
screening programme) constituted the control population.
Polymerase chain reaction amplification
Genomic DNA was extracted from peripheral blood using 
the Gentra PureGene Blood kit (Gentra Systems, Minneapolis, 
Minnesota, USA) and from the buccal smears or filter paper 
blots using Chelex at a final concentration of 0.8 per cent.
Four sets of primers were synthesized, spanning the 
coding region of MSX1 (Exons 1 and 2) and of the PAX9 
gene (Exons 2, 3, and 4) and standard polymerase chain 
reaction (PCR) amplification of genomic DNA was used. 
PCR was performed in a total volume of 25 l containing 
40 ng of DNA, 1 M of each primer, 25 mM MgCl2, 
200 M deoxyribonucleotides, and 0.01 U of DNA Taq 
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100 mM Tris–HCl, pH 8.8, 500 mM KCl buffer. Samples 
were initially heated to 95°C for 5 minutes. Each cycle 
comprised denaturation at 94°C for 1 minute, primer 
annealing at optimal annealing temperature for 30 seconds, 
and extension at 72°C for 1.5 minutes. The samples were 
subjected to 35 cycles of amplification, followed by a final 
extension at 72°C for 7 minutes. The PCR products were 
analysed in 2 per cent agarose gel.
Mutation scanning by single-strand conformation 
polymorphism analysis
A non-radioactive single-strand conformation poly-
morphism (SSCP) method was used to scan for sequence 
variants in the coding region of the MSX1 gene and the 
second exon of the PAX9 gene.
Amplified DNA from these segments was subjected to 
electrophoretic migration on 11 per cent polyacrylamide gel 
with glycerol, under non-denaturing conditions in the 
Multhiphor® apparatus (GE Healthcare Life Sciences, 
Amersham, Buckinghamshire, UK). Different temperatures 
were used for electrophoretic separation for each gene 
segment: 15°C for PAX9, 4°C for Exon 1, and 15°C for 
Exon 2 of the MSX1 gene. The gel was silver stained, using 
standard methods. If any differences were detected, direct 
sequencing was carried out as described below.
DNA sequencing
PCR products were sequenced using the PCR Pre-Sequencing 
Kit (GE Healthcare Life Sciences), according to the 
manufacturer’s instructions. Complete sequencing of the 
coding regions of MSX1 (Exons 1 and 2) and PAX9 gene (Exons 
2, 3, and 4) was performed through automated cycle sequencing 
(ABI Prism® Big Dye Terminator Cycle Sequencing Ready 
Reaction kit; Applied Biosystems, Foster City, California, 
USA), according to the manufacturer’s instructions, using 
the primers listed in Table 1. Capillary electrophoresis was 
performed in an ABI 310 (Applied Biosystems).
Allele-specific PCR
Allele-specific PCR was used to confirm the presence of a 
mutation in the probands and family members and to study 
the frequency of DNA variants in the control population. The 
PCR started with denaturation at 95°C for 5 minutes, followed 
by 32 cycles of denaturation at 94°C for 1 minute, annealing 
at 62°C for 30 seconds, and extension at 72°C for 1 minute. 
A final extension at 72°C for 5 minutes was performed. The 
reaction occurred in a total volume of 12.5 l, containing 100 
mM Tris–HCl, pH 8.8, 500 mM KCl buffer, 1.5 mM MgCl2, 
0.6 mM deoxyribonucleotides, 0.03 per cent formaldehyde, 
and 0.01 U Taq polymerase (Gibco-Invitrogen, Carlsbad, 
California, USA). Subjects of known genotype were 
used in each run to validate the specificity of PCR. The 
amplification products were detected in 2 per cent agarose 
Figure 2 Agarose gel electrophoresis showing the allele-specific 
polymerase chain reaction (PCR) for the study of substitution in the 718 
nucleotide position (G>C): Lanes 1 and 3: G/G homozygous normal 
genotype; Lanes 2, 4, and 5: G/C heterozygous genotype; and Lane 6: C/C 
homozygous mutant genotype. To the left are the negative blank and 
positive controls of the allele-specific PCR.
gel. Figure 2 shows an example of the results obtained 
with this method.
Statistical analysis
Statistical analysis of the data was performed using the 
Statistical Package for Social Sciences version 16 (SPSS 
Inc., Chicago, Illinois, USA). A chi-square test was used 
to compare the frequency of mutations/polymorphisms 
between the probands and controls and between affected 
and non-affected relatives (excluding spouses). A P-value 
less than 0.05 was considered to be statistically significant.
Results
In the proband of each family, Exons 2, 3, and 4 of the PAX9 
gene and Exons 1 and 2 of the MSX1 gene were sequenced, 
with the aim of identifying mutations in these genes. In 
Table 1 Sequence of primers used for amplification of the 
different exons and conditions in polymerase chain reaction. F, 
forward; R, reverse; ex, exon; numeration, nucleotide position in 
the sequence; Ta, annealing temperature (matching temperature).
Gene Primers Sequence Size  
(base pairs)
















Extracted and adapted from Vastardis et al. (1996) and Nieminen et al. 
(2001).
(+) indicates a sequence of DNA that is in front of the codon where tran-
sition begins and (−) the sequence of DNA that is behind the codon.
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MLIA revealed no difference (P = 0.12) in the frequency of 
homozygous and heterozygous carriers of this polymorphism 
compared with that seen in the control population (Table 3). 
Additionally, analysis of the frequency of the Ala240Pro 
polymorphism and corresponding genotypes in affected 
and non-affected cases (excluding individuals who married 
into the basic gene pool; n = 34, Table 3) was performed of 
the 12 families. No significant difference was found in the 
distribution of the Ala240Pro polymorphism between the 
affected and non-affected groups, either when considering 
as affected with agenesis only, or extending the concept of 
‘affected’ to include those with agenesis and/or microdontia. 
(P > 0.05).
Discussion
In this study, no mutations in the MSX1 gene were found in 
individuals with MLIA, while a polymorphism in the PAX9 
gene was detected, the frequency of which was not, however, 
statistically different from that in the control population.
This result reinforces the view that the MSX1 gene might 
be fundamentally implicated in odontogenesis of posterior 
teeth (Nieminen et al., 1995; Vastardis et al., 1996; Scarel 
et al., 2000; Vastardis, 2000; Nieminen et al., 2001; 
these 12 probands, no nucleotide changes were detected in 
the regions of the MSX1 gene analysed by SSCP or 
sequencing. Thus, for this gene, no further mutation analysis 
was performed in the relatives.
Two sequence variants were identified in Exon 3 of 
PAX9: a silent change in nucleotide 717C>T=rs12881240 
in one of the probands, and a variant in nucleotide 
718G>C=rs4904210 (Figure 3) leading to the Ala240Pro 
substitution, in eight probands (66.7 per cent of probands), 
four homozygous, and four heterozygous. In the control 
population of Portuguese ancestry, the frequency of the 
Ala240Pro variant was 56 per cent. The observed 
differences in the frequencies of this polymorphism 
between the probands and controls were not statistically 
significant (chi-square test P = 0.1).
Analysis of these specific variants in PAX9 was also 
performed by allele-specific PCR (Figure 2) in the remaining 
40 family members, eight of which were affected with MLIA. 
The Ala240Pro variant was found in 28 (70 per cent of the 
relatives, nine homozygous and 19 heterozygous) (Figure 1, 
Table 2, available as supplementary data in European Journal 
of Orthodontics online).
Analysis of the distribution of the Ala240Pro 
polymorphism genotypes in PAX9 in the eight families with 
Figure 3 Chromatogram showing the sequencing analysis of Exon 3 of PAX9, from four probands. (A) wild-
type sequence, (B) homozygosity, (C) heterozygosity for the G>C substitution at nt 718, and (D) homozygosity 
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De Muynck et al., 2004; Mostowska et al., 2006). Illustrating 
this concept is the description by Mostowska et al. (2006) 
of a novel mutation of MSX1 with incomplete penetrance, 
potentially responsible for oligodontia in a proband with 
absence of 14 permanent teeth but with the presence of 
the maxillary incisors. Those authors supported the view 
that oligodontia of the human dentition might be an 
oligogenetic trait caused by simultaneous mutation of 
different genes.
Mutations in the PAX9 gene have been associated with 
agenesis of posterior teeth (Stockton et al., 2000; Nieminen 
et al., 2001; Pereira et al., 2006; Hansen et al., 2007; Tallon-
Walton et al., 2007). In humans, unlike mice, a heterozygous 
mutation in either PAX9 or MSX1 was reported to be 
sufficient to cause agenesis of molars or premolars, 
respectively (De Muynck et al., 2004; Kapadia et al., 2007). 
In the present study, the location of the agenesis studied was 
at an anterior level, and a sequence variant in the PAX9 gene 
[nt718 (G>C)] was identified. This nucleotide substitution 
has previously been described (Nieminen et al., 2001), 
leading to the introduction of a proline instead of alanine in 
the peptidic chain. The alanine residue at position 240 is 
conserved during evolution and is present in several species 
(namely Gallus gallus, Mus musculus, Danio rerio, Takifugu 
rubripes), being maintained in rodents and in mammals 
(Pereira et al., 2006). Its substitution by proline could be a 
reason for the structural change in the PAX9 protein with a 
corresponding functional effect. It has been suggested that 
in spite of a globally strong purifying selection acting upon 
PAX9, the Ala240Pro polymorphism may confer an 
evolutionary advantage by causing congenital absence of 
third molars in humans (Pereira et al., 2006). In agreement 
with this hypothesis, this variant was common but was not 
significantly more frequent in individuals with MLIA than 
in the control population in the present study. Homozygosity 
for the variant was not significantly more frequent in the 
MLIA probands than in the controls. Segregation analysis 
and the correlation between genotype–phenotype in the 
MLIA families also did not reveal an association of the 
nt718 (G>C) or of the Ala240Pro variants of PAX9 with 
hypodontia. Family members without agenesis and some 
healthy partners were also heterozygous for the Ala240Pro 
polymorphism, reflecting its frequency in a large proportion 
of the control population.
In the controls, in the present study, the frequency of the 
Ala240Pro variation was 56 per cent, close to that recently 
reported of 69.8 per cent for a southeast Chinese control 
population (Pan et al., 2008). In the latter population, the 
same PAX9 polymorphism alone had a non-significant effect 
on the overall risk of tooth agenesis because no significant 
difference was found in the haplotype distribution between 
the controls and subjects with tooth agenesis or mandibular 
incisor agenesis. A specific haplotype of this gene was, 
however, reported to have a protective effect, being 
associated with a decreased risk of tooth agenesis (Pan 
et al., 2008).
Although previous research of familial aggregation 
(Pinho, 2004) indicated an increased risk of MLIA in 
relatives of affected probands, it was not established in 
this study that MSX1 and PAX9 genes have a relevant 
aetiopathogenic implication for this developmental 
defect, at least in the Portuguese population. This implies 
that several other genes are possibly implicated in the 
pathogenesis of dental agenesis.
Conclusions
Sequence variants in the MSX1 and PAX9 genes, including 
the G718C polymorphism, were not the cause of hypodontia 
in the studied patients. The phenotype of affected probands 
might result from mutations of other developmentally 
relevant candidate genes, yet to be identified.
Table 3 Frequencies of the different genotypes (G/G, C/C, and G/C) observed in the PAX9 gene polymorphism G718C of controls, 
subjects with maxillary lateral incisor agenesis and their relatives.
Studied population Total (n) PAX9 G718C substitution
No Yes
Homozygote normal  
genotype (G/G)
Homozygous (C/C) Heterozygous (G/C)
Probands (individuals with incisor agenesis) 12 4 (33.33%) 4 (33.33%) 4 (33.33%)
Relatives of probands* 34 9 (26.47%) 8 (23.53%) 17 (50%)
 With agenesis 8 4 (50%) 2 (25%) 2 (25%)
 Without agenesis 26 5 (19.23%) 6 (23.08%) 15 (57.69%)
Controls (individuals without incisor agenesis) 91 40 (43.96%) 14 (15.38%) 37 (40.66%)
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Supplementary material
Supplementary material is available at European Journal of 
Orthodontics online.
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